Literature DB >> 3656137

Non-cholinergic component of rat splanchnic nerves predominates at low neuronal activity and is eliminated by naloxone.

R K Malhotra1, A R Wakade.   

Abstract

1. Effects of nicotinic (mecamylamine) and muscarinic (atropine) receptor antagonists were investigated on the secretion of catecholamines evoked by stimulation of splanchnic nerve terminals and acetylcholine in the isolated perfused adrenal gland of the rat to determine whether non-cholinergic substances released from nerve terminals participate in the secretion of catecholamines. 2. Increasing the frequency of stimulation from 0.5 to 10 Hz (300 pulses) caused enhanced secretion of catecholamines (26-110 ng/collection period). After blockade of nicotinic and muscarinic receptors with mecamylamine and atropine, the secretion was reduced by 40, 65 and 80% at 0.5, 1 and 10 Hz, respectively. Acetylcholine-evoked secretion of catecholamines, which was roughly equivalent to that produced by stimulation at 10 Hz, was blocked by over 90% by the cholinergic antagonists. 3. Naloxone (3-300 microM) caused a concentration-dependent inhibition of catecholamine secretion evoked by stimulation of splanchnic nerves (1 Hz); acetylcholine-evoked secretion was much less affected by naloxone. 4. The secretion of catecholamines that remained after blockade of cholinergic receptors at different frequencies of stimulation (see 2 above) was almost completely inhibited by inclusion of 30 microM-naloxone in the medium. The inhibitory effect of naloxone was concentration dependent (3-30 microM) and reversible. 5. Splanchnic nerve-evoked secretion of catecholamines was facilitated by 400% in the presence of tetraethylammonium or tetraethylammonium plus mecamylamine and atropine. The facilitatory effect of tetraethylammonium was inversely related to the frequency of stimulation. 6. The residual secretion of catecholamines obtained after blockade of cholinergic receptors was facilitated by increasing concentrations of tetraethylammonium (1-5 mM). 30 microM-naloxone antagonized the facilitatory effects of tetraethylammonium at 1 and 3 mM by 60% and 25%, respectively, but failed at 5 mM-tetraethylammonium; higher concentrations of naloxone (100 microM) were also ineffective. 7. It is concluded that neurally evoked secretion of catecholamines is mediated by acetylcholine and a non-cholinergic substance(s); the contribution of non-cholinergic substance(s) predominates at low neuronal activity, whereas that of acetylcholine is maximum at high neuronal activity. Blockade of the non-cholinergic component by naloxone suggests that an opioid peptide may be involved in the secretion of catecholamines in the rat adrenal medulla.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3656137      PMCID: PMC1183095          DOI: 10.1113/jphysiol.1987.sp016434

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  26 in total

1.  Isolation and characterization of plasma membranes from the adrenal medulla.

Authors:  S P Wilson; N Kirshner
Journal:  J Neurochem       Date:  1976-12       Impact factor: 5.372

2.  Potentiation by tetraethylammonium of the response of the cat spleen to postganglionic sympathetic nerve stimulation.

Authors:  H Thoenen; W Haefely; H Staehelin
Journal:  J Pharmacol Exp Ther       Date:  1967-09       Impact factor: 4.030

3.  Co-storage and co-secretion of somatostatin and catecholamine in bovine adrenal medulla.

Authors:  H Saito; S Saito; T Ohuchi; M Oka; T Sano; E Hosoi
Journal:  Neurosci Lett       Date:  1984-11-23       Impact factor: 3.046

4.  Distribution of [Met5]- and [Leu5]-enkephalin-, vasoactive intestinal polypeptide- and substance P-like immunoreactivities in human adrenal glands.

Authors:  R I Linnoila; R P Diaugustine; A Hervonen; R J Miller
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

5.  Opioid receptors in bovine adrenal medulla.

Authors:  M Dumont; S Lemaire
Journal:  Can J Physiol Pharmacol       Date:  1984-10       Impact factor: 2.273

6.  Mechanism of presynaptic actions of adenosine and acetylcholine on noradrenaline release in the guinea-pig heart.

Authors:  A R Wakade; T D Wakade
Journal:  Neuroscience       Date:  1982       Impact factor: 3.590

7.  Further evidence for nicotinic and muscarinic receptors and their interaction in dog adrenal medulla.

Authors:  A Tsujimoto; T Nishikawa
Journal:  Eur J Pharmacol       Date:  1975-12       Impact factor: 4.432

8.  Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland.

Authors:  A R Wakade
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

9.  Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma.

Authors:  J M Lundberg; B Hamberger; M Schultzberg; T Hökfelt; P O Granberg; S Efendić; L Terenius; M Goldstein; R Luft
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

10.  Evidence that inhibition of nicotine-mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors.

Authors:  D M Dean; S Lemaire; B G Livett
Journal:  J Neurochem       Date:  1982-03       Impact factor: 5.372

View more
  17 in total

1.  Distinguishing splanchnic nerve and chromaffin cell stimulation in mouse adrenal slices with fast-scan cyclic voltammetry.

Authors:  Paul L Walsh; Jelena Petrovic; R Mark Wightman
Journal:  Am J Physiol Cell Physiol       Date:  2010-11-03       Impact factor: 4.249

2.  Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis.

Authors:  Carol Hamelink; Olga Tjurmina; Ruslan Damadzic; W Scott Young; Eberhard Weihe; Hyeon-Woo Lee; Lee E Eiden
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

3.  Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).

Authors:  L Taupenot; S K Mahata; H Wu; D T O'Connor
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

4.  The peptide VIP is a neurotransmitter in rat adrenal medulla: physiological role in controlling catecholamine secretion.

Authors:  T D Wakade; M A Blank; R K Malhotra; R Pourcho; A R Wakade
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

5.  Adrenal cortical and medullary responses to acetylcholine and vasoactive intestinal peptide in conscious calves.

Authors:  A V Edwards; C T Jones
Journal:  J Physiol       Date:  1993-08       Impact factor: 5.182

Review 6.  Revisiting the stimulus-secretion coupling in the adrenal medulla: role of gap junction-mediated intercellular communication.

Authors:  Claude Colomer; Michel G Desarménien; Nathalie C Guérineau
Journal:  Mol Neurobiol       Date:  2009-05-16       Impact factor: 5.590

7.  The effects of vasoactive intestinal peptide (VIP) antagonists, and VIP and peptide histidine isoleucine antisera on non-adrenergic, non-cholinergic relaxations of tracheal smooth muscle.

Authors:  J L Ellis; S G Farmer
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

8.  Vasoactive intestinal polypeptide stimulates the secretion of catecholamines from the rat adrenal gland.

Authors:  R K Malhotra; A R Wakade
Journal:  J Physiol       Date:  1987-07       Impact factor: 5.182

9.  Multiple signaling pathways in bovine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser19, Ser31, and Ser40.

Authors:  J W Haycock
Journal:  Neurochem Res       Date:  1993-01       Impact factor: 3.996

10.  Non-cholinergic nervous control of catecholamine secretion from perfused bovine adrenal glands.

Authors:  P D Marley; K A Thomson; A Smardencas
Journal:  J Physiol       Date:  1993-06       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.